Market Insight: Medical Device Cleaning Moves Toward Smarter, More Validated Reprocessing

The global medical device cleaning market was valued at USD 31.7 billion in 2026, with the market estimated at USD 34.39 billion in 2027 and projected to reach USD 82.75 billion by 2036, representing a 10.07% CAGR from 2027 to 2036. This expansion reflects a broader shift in healthcare from basic cleaning procedures toward more controlled, validated, and technology-enabled medical device reprocessing.

A major driver is the growing emphasis on infection prevention. Medical devices, particularly reusable instruments, require cleaning processes that are consistent, documented, and compatible with increasingly sophisticated device designs. As hospitals and healthcare facilities face greater expectations around patient safety and procedural compliance, cleaning is increasingly being treated as an integral component of the overall sterilization and reprocessing workflow rather than an isolated preliminary step.

Technology is also changing the competitive requirements of the market. Digital monitoring, validation systems, automated processes, and improved cleaning formulations can help reduce variability between procedures while creating stronger documentation trails. The launch of Solventum's Attest Ebowie-Dick Test System illustrates this movement toward digital assurance within sterilization workflows.

Regional Analysis: North America Leads While Asia Pacific Builds Faster Momentum

Regional market dynamics indicate two distinct growth stories. North America accounted for 35.53% of the market in 2026, giving it the strongest current regional position, while Asia Pacific is expected to record an 11.76% CAGR as healthcare infrastructure and reusable-device utilization expand.

North America's leadership is supported by a mature healthcare ecosystem, extensive medical infrastructure, established infection-prevention practices, and strong demand for validated cleaning and reprocessing solutions. Hospitals and healthcare organizations in the region operate within an environment where process consistency, regulatory expectations, and infection-control requirements make advanced cleaning technologies strategically important.

The region also benefits from an established ecosystem of specialized companies serving sterilization, disinfection, infection prevention, and medical device processing applications. Recent activity from companies such as Sterigenics, Ecolab, Solventum, and STERIS demonstrates the breadth of commercial activity surrounding the broader sterilization and infection-control value chain.

Asia Pacific presents a different opportunity profile. Its faster projected growth is closely associated with expanding healthcare infrastructure, greater adoption of reusable medical devices, and increasing hospital investment in reliable cleaning and reprocessing systems. As healthcare capacity develops, demand is likely to extend beyond basic equipment toward standardized processes capable of supporting larger and more complex clinical environments.

Industry Challenge: Cleaning Validation and Process Consistency Remain Critical Barriers

Despite strong market momentum, medical device cleaning remains operationally demanding because effective reprocessing depends on more than simply applying a cleaning product. Healthcare providers must achieve repeatable outcomes across different device designs, clinical environments, staff workflows, and reprocessing conditions.

One of the industry's central challenges is process standardization. Reusable medical devices can vary substantially in geometry, material composition, complexity, and accessibility of surfaces. This makes it difficult for healthcare organizations to rely on a single cleaning approach across every application.

Documentation and validation add another layer of complexity. As infection-control expectations become more rigorous, healthcare providers need greater confidence that cleaning procedures are being performed correctly and consistently. The move toward digital monitoring and assurance tools is partly a response to this challenge, as these technologies can help reduce dependence on manual interpretation and provide more structured evidence of process performance.

Product and Technology Comparison: Conventional Cleaning Processes vs. Digital-Assured Reprocessing

Medical device cleaning is increasingly developing along two complementary approaches: conventional cleaning and reprocessing workflows and digitally supported, validation-oriented systems.

Conventional approaches remain fundamental because physical cleaning, chemical treatment, rinsing, inspection, and preparation are essential parts of reusable-device processing. Their key advantage is established integration into hospital workflows. Healthcare facilities are already familiar with these procedures and have infrastructure, personnel, and operating protocols designed around them.

Digitally supported approaches address a different part of the problem. Systems such as Solventum's Attest Ebowie-Dick Test System demonstrate how digital tools can support sterilization assurance by reducing manual interpretation and documentation requirements. These technologies are particularly relevant where healthcare providers want stronger process visibility and more reliable records.

The two approaches should not necessarily be viewed as substitutes. Digital systems can instead augment established physical cleaning and sterilization workflows by improving monitoring, assurance, and documentation.

Approach	Primary Strength	Key Opportunity
Conventional reprocessing	Established workflows and broad operational familiarity	Improving consistency and efficiency
Digital-assisted assurance	Greater monitoring, documentation, and process visibility	Supporting validation and reducing manual interpretation

The commercial opportunity lies in connecting these approaches. Providers that can integrate digital assurance into practical reprocessing environments may help healthcare organizations improve process control without requiring a complete redesign of existing operations.

Geographic Opportunity: Four Markets With Strategic Relevance

United States

The United States represents a particularly important market opportunity because North America holds the leading regional position. Its extensive healthcare infrastructure and strong emphasis on infection prevention create demand for validated cleaning, sterilization, and reprocessing solutions. Recent expansion by Sterigenics and laboratory investment by Ecolab further demonstrate the depth of industry activity in the U.S. healthcare ecosystem.

China

China represents a significant longer-term opportunity within Asia Pacific as healthcare infrastructure continues to develop and hospitals increasingly require modern medical device processing capabilities. The region's projected growth trajectory makes China strategically relevant for companies seeking exposure to expanding healthcare systems and increasing adoption of reusable medical devices.

India

India is another important Asia Pacific opportunity because healthcare infrastructure development can create demand for modern infection-control and medical device reprocessing capabilities. For suppliers, the strategic opportunity extends beyond individual cleaning products toward integrated systems that can support hospitals as their operational requirements become more sophisticated.

Japan

Japan offers a contrasting opportunity within Asia Pacific, combining an established healthcare system with potential demand for high-quality, reliable, and technologically advanced reprocessing solutions. Its relevance is particularly strong for suppliers focused on process consistency, device compatibility, validation, and operational efficiency.

Competitive Landscape: Companies Are Expanding Beyond Traditional Cleaning Solutions

The competitive landscape increasingly reflects convergence between sterilization services, infection prevention, laboratory capabilities, digital assurance, standards development, and medical device reprocessing.

Sterigenics is strengthening its U.S. sterilization footprint through expansion plans that include a new X-ray sterilization facility at its Haw River, North Carolina campus. The move indicates continued investment in sterilization infrastructure and suggests that capacity expansion remains an important competitive lever as healthcare demand develops.

Ecolab is broadening its technical capabilities through a bioprocessing applications laboratory in King of Prussia, Pennsylvania. The development reinforces the growing relationship between infection control, process optimization, and specialized technical support.

Solventum is taking a more technology-oriented approach through its Attest Ebowie-Dick Test System. Its focus on reducing manual interpretation and documentation points toward a market where digital assurance can become increasingly important.

ASTM International is contributing from a standards perspective, advancing science-, risk-, and statistics-based standards for medical and pharmaceutical cleaning applications. Standardization can have an important indirect effect on market development by creating clearer frameworks for validation and operational best practices.

STERIS continues to maintain visibility across healthcare customers through its sterilization and infection-prevention portfolio, while APIC is advocating regulatory reform concerning medical device instructions for use. These activities demonstrate that competitive positioning is influenced not only by product offerings but also by standards, regulatory developments, education, and stakeholder engagement.

Recent Industry News: Developments Point to a More Technology- and Standards-Driven Market

Recent industry developments demonstrate how medical device cleaning and the wider sterilization ecosystem are evolving toward greater capacity, digital assurance, technical specialization, and standardized processes.

May 2025 — Sterigenics: Sterigenics announced expansion plans that include a new X-ray sterilization facility at its Haw River, North Carolina campus. The investment is significant because expanding sterilization infrastructure can improve capacity while strengthening the company's position in advanced sterilization services for healthcare and medical device applications.

May 2025 — Ecolab: Ecolab opened a bioprocessing applications laboratory in King of Prussia, Pennsylvania. The facility is designed to support biopharma process development and purification activities, while also expanding Ecolab's technical capabilities in contamination control and process optimization. The development illustrates how infection prevention is increasingly connected with specialized technical and process expertise.

March 2025 — Solventum: Solventum launched the Attest Ebowie-Dick Test System, a digital sterilization assurance solution designed to reduce manual interpretation and documentation in sterilization workflows. The development highlights the industry's movement toward digital monitoring and stronger process reliability.

January 2025 — ASTM International: ASTM International advanced science-, risk-, and statistics-based standards for medical and pharmaceutical cleaning applications. Continued standards development can help establish more consistent approaches to cleaning validation and strengthen the technical framework supporting the industry.

August 2024 — STERIS: STERIS participated in the Morgan Stanley Healthcare Conference, using the platform to showcase its sterilization and infection-prevention portfolio. Such industry engagement reinforces the importance of sterilization and infection prevention within broader healthcare technology discussions.

May 2024 — APIC: The Association for Professionals in Infection Control and Epidemiology advocated regulatory reform concerning medical device instructions for use. The initiative focuses on improving the consistency, clarity, and oversight of cleaning protocols used in healthcare settings, highlighting the regulatory dimension of medical device reprocessing.

February 2021 — Getinge: Getinge partnered with researchers at the University of Gothenburg to advance innovation and sustainability initiatives in infection prevention and related healthcare technologies. The collaboration demonstrates that sustainability and long-term improvements in medical device reprocessing are becoming part of the industry's innovation agenda.

Read more about this report @ https://www.fundamentalbusinessinsights.com/industry-report/medical-device-cleaning-market-14548

About

Fundamental Business Insights:

Fundamental Business Insights is global market research and consulting company which is engaged in providing in depth market reports to its various types of clients like industrial sectors, financial sectors, universities, non-profit, and corporations. Our goal is to offer the correct information to the right stakeholder at the right time, in a format that enables logical and informed decision making. We have a team of consultants who have experience in offering executive level blueprints of markets and solutions. Our services include syndicated market studies, customized research reports, and consultation.

Contact us:
Robbin Fernandez
Head of Business Development
Fundamental Business Insights and Consulting
Email:  sales@fundamentalbusinessinsights.com

Read This Report in Regional Languages - 

https://www.fundamentalbusinessinsights.com/ko/industry-report/medical-device-cleaning-market-14548

https://www.fundamentalbusinessinsights.com/ja/industry-report/medical-device-cleaning-market-14548

https://www.fundamentalbusinessinsights.com/de/industry-report/medical-device-cleaning-market-14548

https://www.fundamentalbusinessinsights.com/it/industry-report/medical-device-cleaning-market-14548

https://www.fundamentalbusinessinsights.com/es/industry-report/medical-device-cleaning-market-14548

https://www.fundamentalbusinessinsights.com/fr/industry-report/medical-device-cleaning-market-14548